Shares of Korro Bio, Inc. (KRRO) have gained 6.7% over the past four weeks to close the last trading session at $39.76, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $135 indicates a potential upside of 239.5%. The mean estimate comprises five short-term price targets with a standard deviation of $42.13. While the lowest estimate of $95 indicates a 138.9% increase from the cur ...